The Bcl-2 protein family is crucial in regulating apoptosis, with members functioning either as promoters or inhibitors of cell death, thereby playing significant roles in cancer progression and treatment resistance. Understanding the balance and interactions among these proteins can illuminate pathways for therapeutic intervention in diseases characterized by excessive cell survival.